35º informe del Comité de Expertos de la OMS en Farmacodependencia

El objetivo de la reunión era revisar una serie de sustancias y asesorar a la Organización Mundial de la Salud sobre la posible clasificación de estas en el marco de las convenciones de fiscalización internacional de drogas. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

The thirty-fifth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Hammamet, Tunisia from 4 to 8 June 2012.

The role of WHO is the assessment of medical properties and the liability for abuse of any substance, pure chemical or plant material, and to advise the United Nations Commission on Narcotic Drugs (CND) on which substances should be under international control.

The purpose of this meeting of the ECDD was, therefore, to review a number of substances and to provide its advice to WHO on whether these substances should be recommended for scheduling under the international drug control conventions (in case of critical reviews) and recommend whether a critical review should be held at a subsequent meeting of the ECDD (in case of a pre-review).

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.